News and hot topics
Beyond the Capsule: Unlocking the Full Potential of Lipid Excipients in Oral Solid Dosage Forms
Reading : 1mn
Learn how established lipid chemistries offer a safe, scalable approach to overcome in vivo barriers and accelerate your next tablet formulation to market.
Oral peptide delivery with lipid-based excipients
In this article, we explore why lipids and peptides are compatible, how lipid based formulations can address key peptide oral delivery challenges, and how Gattefossé supports formulators in this rapidly evolving field.
Streamline Your Journey from Feasibility to Formulation
Gattefossé's Technical Center of Excellence in Paramus, NJ, is your guide to lipid-based formulation development, helping you screen, optimize, and de-risk projects. Whether you're new to lipid formulations or simply looking for hands-on support, our TCE lab is here to help!
Meet Gattefossé at AAPS PharmSci 360
Learn how we enhance your formulation journey across a range of dosage forms.
In the spotlight: spot-on solutions!
Discover how Gattefossé excipients enhance the formulation of spot-on veterinary treatments!
Soft chews, the pet-fect dosage form!
Learn how Gattefossé excipients can be used for this convenient veterinary dosage form!
Transcutol® V, your ally for formulating veterinary medicines
This excipient is a must when it comes to the formulation of veterinary medicines, as it can be used for oral, topical, and parenteral dosage forms.
The basics of intestinal permeation
Improving the oral bioavailability of pharmaceuticals is a challenging task, heavily influenced by the solubility and permeability of the active pharmaceutical ingredient. Intestinal permeation enhancers, such as medium chain fatty acid esters, play a crucial role in this context by facilitating the passage of drugs through the intestinal barrier, thus improving their absorption and therapeutic efficacy.